View Author
patient cancer study treatment depression family effect change group side effects baseline scale distress women month ifn-a symptom disorder depressive van gool ar activity result interferon concentration level testing mutation control score 8 weeks therapy psychiatry tryptophan hepatitis c ratio bannink pagina 20-12-2005 bannink m melanoma breast cancer 6 months hepatitis anxiety center breast table plasma system melanoma patients cancer distress increase brca 1/2 1/2 4 weeks ifn-alfa participant range control group cytokine kruit whj hnpcc rating platelet support platelet mao activity research individual rotterdam syndrome illness decrease netherland relationship parameter fekke van gool sample prophylactic oncology
10 Most Recent Publications
|
Randomised clinical trial: Escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C
(Article)
Knegt, R.J. de Bezemer, G. Gool, A.R. van Drenth, J.P.H. Hansen, B.E. Droogleever Fortuyn, H.A. Weegink, C.J. Hengeveld, M.W. Janssen, H.L.A. |
2011-12-01
|
|
Severe akathisia as a side effect of metoclopramide
(Article)
Gool, A.R. van Doorduijn, J.K. Seynaeve, C.M. |
2010-12-01
|
|
The prefrontal cortex as a target for antipsychotic agents [De prefrontale cortex als aangrijpingspunt voor antipsychotica]
(Article)
Jong, M.H. de Gool, A.R. van Loonen, A.J.M. |
2010-01-01
|
|
Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-a therapy
(Article)
Fekkes, D. Gool, A.R. van Bannink, M. Sleijfer, S. Kruit, W.H.J. Holt, B. van der Eggermont, A.M.M. Hengeveld, M.W. Stoter, G. |
2009-10-01
|
|
Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy
(Article)
Tan, M.B.M. Bleiker, E.M.A. Seynaeve, C.M. Menke-Pluymers, M.B.E. Gool, A.R. van Dooren, S. van Geel, B.N. van Tilanus-Linthorst, M.M.A. Bartels, C.C.M. Klijn, J.G.M. Brekelmans, C.T. |
2009-03-31
|
|
Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-α: Course and relationship with psychiatric status
(Article)
Gool, A.R. van Verkerk, R. Hengeveld, M.W. Fekkes, D. Bannink, M. Sleijfer, S. Kruit, W.H.J. Holt, B. van der Scharpé, S. Eggermont, A.M.M. Stoter, G. |
2008-10-01
|
|
Misattribution of agency in schizophrenia: An exploration of historical first-person accounts
(Article)
Maes, J.P.M.A. Gool, A.R. van |
2008-06-01
|
|
Plasma activity of prolyl endopeptidase in relation to psychopathology during immunotherapy with IFN-α in patients with renal cell carcinoma
(Article)
Gool, A.R. van Verkerk, R. Hengeveld, M.W. Fekkes, D. Sleijfer, S. Bannink, M. Kruit, W.H.J. Holt, B. van der Scharpé, S. Eggermont, A.M.M. Stoter, G. |
2008-05-01
|
|
Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated
(Article)
Bannink, M. Kruit, W.H.J. Gool, A.R. van Sleijfer, S. Holt, B. van der Eggermont, A.M.M. Stoter, G. Hengeveld, M.W. |
2008-01-01
|
|
The common sense model of self-regulation and psychological adjustment to predictive genetic testing: A prospective study
(Article)
Oostrom, I.I.H. van Meijers-Heijboer, E.J. Duivenvoorden, H.J. Bröcker-vriends, A.H.J.T. Asperen, C.J. van Sijmons, R.H. Seynaeve, C.M. Gool, A.R. van Klijn, J.G.M. Tibben, A. |
2007-12-01
|
